1. SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA. Issue 2 (6th February 2019) Authors: Sarafidis, Pantelis; Ferro, Charles J; Morales, Enrique; Ortiz, Alberto; Malyszko, Jolanta; Hojs, Radovan; Khazim, Khaled; Ekart, Robert; Valdivielso, Jose; Fouque, Denis; London, Gérard M; Massy, Ziad; Ruggenenti, Petro; Porrini, Esteban; Wiecek, Andrej; Zoccali, Carmine; Mallamaci, Francesca; H... Journal: Nephrology dialysis transplantation Issue: Volume 34:Issue 2(2019) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗